Check-Cap Ltd Ord (CHEK) |
|
1.15 -0.23 (-16.67%)
|
03-05 08:56 |
|
Open: |
1.28 |
Pre. Close: |
1.38 |
|
High:
|
1.345 |
Low:
|
1.05 |
|
Volume:
|
6,059,445 |
Market Cap:
|
53M |
|
|
|
|
Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 56 full-time employees The firm is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The firm's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The firm's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.351 - 1.362 |
1.362 - 1.37 |
|
Low:
|
1.032 - 1.041 |
1.041 - 1.048 |
|
Close:
|
1.136 - 1.153 |
1.153 - 1.163 |
|
Technical analysis |
as of: 2021-03-05 8:08:29 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 2.19 One year: 2.79 |
| Support: |
Support1: 1.05 Support2: 0.87 |
| Resistance: |
Resistance1: 1.88 Resistance2: 2.39 |
| Pivot: |
1.61 |
| Moving Average: |
MA(5): 1.36 MA(20): 1.66
MA(100): 0.89  MA(250): 0.73 |
| MACD: |
MACD(12,26): -0.06 Signal(9): 0.02 |
| Stochastic oscillator: |
%K(14,3): 13.79 %D(3): 16.37 |
| RSI: |
RSI(14): 38.43 |
| 52-week: |
High: 2.93 Low: 0.24 Change(%): -18.4 |
| Average Vol(K): |
3-Month: 1963561 10-Days: 433166 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CHEK has closed above bottom band by 9.0%. Bollinger Bands are 106.1% wider than normal. The large width of the bands suggest high volatility as compared to CHEK's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 25 Jan 2021
What is Wall Street's Target Price for Check Cap Ltd (CHEK) Stock? - InvestorsObserver
Wed, 13 Jan 2021
Check-Cap Ltd. - Consensus Indicates Potential 6.7% Upside - DirectorsTalk Interviews
Mon, 11 Jan 2021
Premarket Mover: Check Cap Ltd (CHEK) Up 4.22% - InvestorsObserver
Wed, 06 Jan 2021
Check-Cap Ltd. - Consensus Indicates Potential 280.4% Upside - DirectorsTalk Interviews
Wed, 06 Jan 2021
Should You Buy Check Cap Ltd (CHEK) Stock Wednesday? - InvestorsObserver
Mon, 04 Jan 2021
Check-Cap Ltd. - Consensus Indicates Potential 307.0% Upside - DirectorsTalk Interviews
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Outperform |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
46 |
| Shares Float (M) |
43 |
|
% Held by Insiders
|
8.59 |
|
% Held by Institutions
|
4.47 |
|
Shares Short (K)
|
5,590 |
|
Shares Short P. Month (K)
|
771 |
Stock Financials |
|
EPS
|
-0.660 |
|
EPS Est This Year
|
-0.630 |
|
EPS Est Next Year
|
-0.570 |
|
Book Value (p.s.)
|
0.440 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-48.0 |
|
Return on Equity (ttm)
|
-91.3 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.296 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-1.74 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.61 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-4.11 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
